We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Cardiology

Cardiology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Refining Non-Invasive Diagnosis of HFpEF: Enhanced Exercise Stress Echocardiography with Left Atrial Compliance Assessment
CardiologyLeft Atrial ComplianceDiagnostic Algorithms

Refining Non-Invasive Diagnosis of HFpEF: Enhanced Exercise Stress Echocardiography with Left Atrial Compliance Assessment

By MedXY|Sep 15, 2026

This multicentre study reveals that combining resting left atrial compliance with exercise stress echocardiography significantly improves diagnostic accuracy for HFpEF, potentially reducing the need for invasive testing in patients with une

Heart Failure in Portuguese Adults Aged 50 and Above: Insights from the PORTHOS Study on Prevalence and Predominant Phenotypes
CardiologyHFpEFepidemiology

Heart Failure in Portuguese Adults Aged 50 and Above: Insights from the PORTHOS Study on Prevalence and Predominant Phenotypes

By MedXY|Sep 15, 2026

The PORTHOS study reveals a 16.5% prevalence of heart failure among Portuguese adults aged 50+, with HFpEF constituting over 90% of cases, mostly undiagnosed, highlighting the need for enhanced screening strategies in aging populations.

Physiological Left Atrial Staging as a Predictor of New-Onset Atrial Fibrillation in Hypertrophic Cardiomyopathy
Cardiologyrisk stratificationHypertrophic Cardiomyopathy

Physiological Left Atrial Staging as a Predictor of New-Onset Atrial Fibrillation in Hypertrophic Cardiomyopathy

By MedXY|Sep 15, 2026

A novel left atrial (LA) staging system, integrating hemodynamic load and contractile function, predicts new-onset atrial fibrillation risk in hypertrophic cardiomyopathy and may guide tailored AF surveillance.

Metabolic Splicing Nexus: HNRNPK Lactylation Drives Inflammation and Injury in Myocardial Ischemia/Reperfusion
Cardiologycardiac inflammationmyocardial ischemia/reperfusion

Metabolic Splicing Nexus: HNRNPK Lactylation Drives Inflammation and Injury in Myocardial Ischemia/Reperfusion

By MedXY|Sep 15, 2026

Lactylation of HNRNPK at K405 links metabolic stress to inflammatory RNA splicing, promoting pathological Jag2 isoform expression and exacerbating myocardial ischemia/reperfusion injury, revealing novel therapeutic targets.

Rapid Immunoassay for Molecular Subphenotyping in Pediatric Acute Cardiorespiratory Failure: Clinical Implications and Future Directions
Cardiologyprecision medicinemolecular subphenotypes

Rapid Immunoassay for Molecular Subphenotyping in Pediatric Acute Cardiorespiratory Failure: Clinical Implications and Future Directions

By MedXY|Sep 13, 2026

Rapid immunoassay-based classifiers accurately identify hyper- and hypoinflammatory subphenotypes in critically ill children, preserving prognostic and predictive utility and enabling precision therapies in acute pediatric cardiorespiratory

Menopausal Hormone Therapy and Cardiovascular Risk in Midlife Women with Vasomotor Symptoms: Insights from the SWAN Study
CardiologySWAN studyRace

Menopausal Hormone Therapy and Cardiovascular Risk in Midlife Women with Vasomotor Symptoms: Insights from the SWAN Study

By MedXY|Sep 13, 2026

Initiation of menopausal hormone therapy during perimenopause or early postmenopause in women with vasomotor symptoms is associated with a reduced cardiovascular risk, especially among Black women and those starting therapy within 10 years

Molecular Subtypes in Transthyretin Cardiac Amyloidosis: Insights from Proteomics Profiling and Tafamidis Efficacy
CardiologyATTR-CAtafamidis

Molecular Subtypes in Transthyretin Cardiac Amyloidosis: Insights from Proteomics Profiling and Tafamidis Efficacy

By MedXY|Sep 13, 2026

Comprehensive plasma proteomics reveal three molecular subtypes of transthyretin cardiac amyloidosis linked to distinct prognoses and differential tafamidis treatment responses, highlighting personalized therapeutic opportunities.

Unraveling the Vascular Impact of Immune Checkpoint and VEGF Inhibitors: Insights from PET Imaging and Immune Profiling
Cardiologyarterial inflammationatherothrombosis

Unraveling the Vascular Impact of Immune Checkpoint and VEGF Inhibitors: Insights from PET Imaging and Immune Profiling

By MedXY|Sep 13, 2026

This study reveals that immune checkpoint and VEGF inhibitors, alone or combined, do not induce detectable arterial inflammation by PET, suggesting macrophage-driven plaque activation is not the main cause of related atherothrombotic events

Tropical Cyclones and Acute Coronary Syndromes: Unraveling the Cardiovascular Burden in Mainland China
CardiologyChinacardiovascular risk

Tropical Cyclones and Acute Coronary Syndromes: Unraveling the Cardiovascular Burden in Mainland China

By MedXY|Sep 12, 2026

A nationwide Chinese study reveals that exposure to tropical cyclones increases acute coronary syndrome risk by 14%, delays treatment times, and disproportionately affects vulnerable populations. Coordinated public health and clinical strat

Genetic Insights into Early Heart Failure Risk in Hypoplastic Left Heart Syndrome: Findings from the NC-DEFINE Study
Cardiologycardiomyopathygenetic screening

Genetic Insights into Early Heart Failure Risk in Hypoplastic Left Heart Syndrome: Findings from the NC-DEFINE Study

By MedXY|Sep 12, 2026

A prospective study reveals that ultra-rare cardiomyopathy gene variants significantly increase risk for early heart failure in infants with hypoplastic left heart syndrome, highlighting potential for genetic risk stratification and precisi

Expanding Horizons in Dilated Cardiomyopathy: A Comprehensive Genetic Reassessment in 2024
CardiologygeneticsGene Curation

Expanding Horizons in Dilated Cardiomyopathy: A Comprehensive Genetic Reassessment in 2024

By MedXY|Sep 12, 2026

The 2024 update of the Clinical Genome Resource elucidates a rapidly expanding genetic landscape for dilated cardiomyopathy, enhancing clinical genetic interpretation with 35 genes classified as high evidence, including nine novel discoveri

Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial Fibrillation
Cardiologyepidemiologydiabetes

Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial Fibrillation

By MedXY|Sep 12, 2026

This study analyzes global trends comparing ischemic stroke burdens linked to diabetes and atrial fibrillation, revealing a rising impact of diabetes-related stroke and highlighting the need for targeted interventions.

Aspirin Use, Lipoprotein(a), and Calcific Aortic Valve Disease: Insights from the Multi-Ethnic Study of Atherosclerosis
CardiologyLipoprotein(a)calcific aortic valve disease

Aspirin Use, Lipoprotein(a), and Calcific Aortic Valve Disease: Insights from the Multi-Ethnic Study of Atherosclerosis

By MedXY|Sep 11, 2026

This review synthesizes evidence linking aspirin use to reduced risk of calcific aortic valve disease in persons with elevated lipoprotein(a), highlighting the potential for targeted preventive strategies.

Advancing Prognostic Precision in HFpEF: The LIFE-Preserved Risk Prediction Model
CardiologyHFpEFheart failure

Advancing Prognostic Precision in HFpEF: The LIFE-Preserved Risk Prediction Model

By MedXY|Sep 11, 2026

The LIFE-Preserved model accurately predicts short-term and lifetime risks of heart failure hospitalization or cardiovascular death in HFpEF patients, enabling tailored clinical risk stratification and improved management.

Linking Air Pollution to Heart Health: Chronic PM2.5 Exposure and Coronary Endothelial Dysfunction
Cardiologycoronary artery diseasePM2.5

Linking Air Pollution to Heart Health: Chronic PM2.5 Exposure and Coronary Endothelial Dysfunction

By MedXY|Sep 11, 2026

Chronic exposure to fine particulate matter (PM2.5) is linked to epicardial coronary endothelial dysfunction, an early marker of coronary artery disease, as demonstrated by invasive coronary vasoreactivity testing.

Long-Term Benefits of Quantitative Flow Ratio-Guided PCI: Insights from the 5-Year FAVOR III China Trial
Cardiologycoronary artery diseaselong-term outcomes

Long-Term Benefits of Quantitative Flow Ratio-Guided PCI: Insights from the 5-Year FAVOR III China Trial

By MedXY|Sep 11, 2026

The FAVOR III China trial demonstrates that QFR-guided percutaneous coronary intervention significantly reduces major adverse cardiac events over 5 years, mainly by decreasing myocardial infarction and ischemia-driven revascularization comp

Advancing Arrhythmic Risk Stratification in Nonischemic Dilated Cardiomyopathy: The Role of LGE Corridors and Genetic Markers
CardiologyLGE corridorsVentricular Arrhythmia

Advancing Arrhythmic Risk Stratification in Nonischemic Dilated Cardiomyopathy: The Role of LGE Corridors and Genetic Markers

By MedXY|Sep 11, 2026

Integration of late gadolinium enhancement corridors and high-risk genotypes markedly improves ventricular arrhythmic risk prediction beyond traditional ejection fraction metrics in nonischemic dilated cardiomyopathy.

Macrotroponin Complexes and Risk of Cardiovascular Events: Implications for Cardiac Troponin Testing in Population Risk Stratification
CardiologyCardiac troponincardiovascular risk

Macrotroponin Complexes and Risk of Cardiovascular Events: Implications for Cardiac Troponin Testing in Population Risk Stratification

By MedXY|Sep 11, 2026

Macrotroponin complexes commonly cause discordant cardiac troponin elevations in the general population, notably troponin I, without conferring increased cardiovascular risk, underscoring the need to recognize assay interference for accurat

Early Identification of PVOD/PCH in Pulmonary Arterial Hypertension: Introducing a Novel Clinical Likelihood Score
Cardiologypulmonary arterial hypertensiondiagnosis

Early Identification of PVOD/PCH in Pulmonary Arterial Hypertension: Introducing a Novel Clinical Likelihood Score

By MedXY|Sep 11, 2026

A newly developed clinical likelihood score accurately distinguishes pulmonary arterial hypertension patients with venous or capillary involvement (PVOD/PCH), enabling earlier diagnosis, tailored therapy, and timely transplant referral.

Ischaemic Stroke Risk in Atrial Flutter Versus Atrial Fibrillation: Insights from a Finnish Nationwide Registry Study
CardiologyanticoagulationIschaemic Stroke

Ischaemic Stroke Risk in Atrial Flutter Versus Atrial Fibrillation: Insights from a Finnish Nationwide Registry Study

By MedXY|Sep 9, 2026

This Finnish nationwide study demonstrates that patients with atrial flutter have a substantially lower risk of ischaemic stroke compared to those with atrial fibrillation, highlighting important differences in thromboembolic risk profiles

Prev
4 / 25
123456…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles